Mechanical thrombectomy performs similarly in real world practice: a 2016 nationwide study from the Czech Republic
Language English Country Great Britain, England Media print-electronic
Document type Journal Article, Meta-Analysis
PubMed
29146830
DOI
10.1136/neurintsurg-2017-013534
PII: neurintsurg-2017-013534
Knihovny.cz E-resources
- Keywords
- stroke, thrombectomy,
- MeSH
- Carotid Artery, Internal diagnostic imaging MeSH
- Stroke diagnostic imaging epidemiology therapy MeSH
- Infarction, Middle Cerebral Artery diagnostic imaging epidemiology therapy MeSH
- Middle Aged MeSH
- Humans MeSH
- Pragmatic Clinical Trials as Topic methods MeSH
- Registries MeSH
- Retrospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Stents * MeSH
- Thrombectomy adverse effects methods trends MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Meta-Analysis MeSH
- Geographicals
- Czech Republic epidemiology MeSH
BACKGROUND: Randomized clinical trials have proven mechanical thrombectomy (MT) to be a highly effective and safe treatment in acute stroke. The purpose of this study was to compare neurothrombectomy data from the Czech Republic (CR) with data from the HERMES meta-analysis. METHODS: Available nationwide data for the CR from 2016 from the Safe Implementation of Treatments in Stroke-Thrombectomy (SITS-TBY) registry for patients with terminal internal carotid artery (ICA) and/or middle cerebral artery (MCA) occlusions were compared with data from HERMES. CR and HERMES patients were comparable in age, sex, and baseline National Institutes of Health Stroke Scale scores. RESULTS: From a total of 1053 MTs performed in the CR, 845 (80%) were reported in the SITS-TBY. From these, 604 (72%) were included in this study. Occlusion locations were as follows (CR vs HERMES): ICA 22% versus 21% (P=0.16), M1 MCA 62% versus 69% (P=0.004), and M2 MCA 16% versus 8% (P<0.0001). Intravenous thrombolysis was given to 76% versus 83% of patients, respectively (P=0.003). Median onset to reperfusion times were comparable: 232 versus 285 min, respectively (P=0.66). A modified Thrombolysis in Cerebral Infarction score of 2b/3 was achieved in 74% (433/584) versus 71% (390/549) of patients, respectively (OR 1.17, 95% CI 0.90-1.5, P=0.24). There was no statistically significant difference in the percentage of parenchymalhematoma type 2 (OR 1.12, 95% CI 0.66-1.90, P=0.68). A modified Rankin Scale score of 0-2 at 3 months was achieved in 48% (184/268) versus 46% (291/633) of patients, respectively (OR 0.92, 95% CI 0.71-1.18, P=0.48). CONCLUSIONS: Data on efficacy, safety, and logistics of MT from the CR were similar to data from the HERMES collaboration.
Department of Neurology Charles University 2nd Medical Faculty Prague Czech Republic
Department of Neurology Hospital Ceske Budejovice Statutory City Czech Republic
Department of Neurology Military University Hospital Prague Canada
Department of Neurology Na Homolce Hospital Prague Czech Republic
Department of Neurology Palacky University Medical School Olomouc Czech Republic
Department of Radiology Masaryk Hospital Usti nad Labem Czech Republic
Neurocentre Regional Hospital Liberec Liberec Czech Republic
References provided by Crossref.org
Thrombectomy vs medical management in low NIHSS acute anterior circulation stroke